Vidaza® | |
Brand Name: | Vidaza |
Active Ingredient: | Azacitidine |
Strength(s): | 25 mg/ml |
Dosage Form(s): | Injection |
Company Name: | Pharmion Corporation |
Availability: | Prescription only |
*Date Approved by FDA: | May 19, 2004 |
*Approval by FDA does not mean that the drug is available for consumers at this time. |
What is Vidaza used for?
Vidaza
is used to treat patients with myelodysplastic syndrome (MDS).
Myelodysplastic syndrome (MDS) is a group of conditions caused by a
problem in the blood-forming cells of bone marrow. Who should not be treated with Vidaza?
You
should not be given Vidaza if you:
Vidaza
may cause harm to a fetus. Women should avoid becoming
pregnant and should not breastfeed while receiving treatment with Vidaza.
Men should avoid fathering a child while receiving treatment with Vidaza. Vidaza
may lead to low white blood cell count (neutropenia)
and low platelet count (thrombocytopenia).Your doctor
check your blood cell counts regularly
to monitor your response and reactions
to Vidaza. What should I tell my health care
provider? Tell
your health care provider if you: ·
have liver problems ·
have kidney problems ·
are pregnant, are trying to
become pregnant, or are breast-feeding Tell your
health care provider about all the medicines you take, including
prescription and non-prescription medicines, vitamins, and herbal
supplements. What are some possible side effects of
Vidaza? (This
list is NOT a complete list of side effects reported with Vidaza.
Your health care provider can discuss with you a more complete list
of side effects.) The
most common side effects with Vidaza include:
Posted:8/12/04 |